A multicenter Spanish study of atropine 0.01% in childhood myopia progression

Abstract To evaluate the efficacy and safety of atropine 0.01% eye drops for myopia control in a multicentric pediatric Spanish cohort. An interventional, prospective, multicenter study was designed. Children aged between 6 and 14 years, with myopia between − 2.00 D to − 6.00 D, astigmatism < 1.5...

Full description

Bibliographic Details
Main Authors: Inés Pérez-Flores, Beatríz Macías-Murelaga, Jesús Barrio-Barrio, Multicenter Group of Atropine Treatment for Myopia Control (GTAM)
Format: Article
Language:English
Published: Nature Portfolio 2021-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-00923-1